The AAMD is the only professional organization dedicated to promoting and supporting the medical dosimetry and treatment professions. Our mission statement includes an important focus on advocacy:

  • Monitoring the healthcare landscape and informing our members of changes that may impact the medical dosimetry and treatment planning profession

Radiation Onoclogy Alternative Payment Model (RO Model)

One of the ways the AAMD advocates for the profession is to follow pending changes in healthcare reimbursement. In July of 2019, the Centers for Medicare Medicaid Services (CMS) announced a proposed Radiation Oncology Alternative Payment Model (RO Model) that will likely have an impact on a large number of clinics and radiation oncology professionals around the country. The AAMD has continued to monitor the RO APM over the past year. 

Update: RO Model Final Rule Issued (September 2020)

On September 18, 2020, CMS issued the final rule for the RO Model for CY 2021. Following that announcement, the AAMD signed onto a letter with nine other medical societies to request urgent changes to the final rule, including a delay in the start date, which CMS stated will be January 1, 2021.

October 2, 2020: Medical Societies' Letter to CMS

During the comment period in 2019, the AAMD Board of Directors communicated with the leaders of ASTRO and AAPM about their specific concerns and then drafted a letter to CMS expressing AAMD’s concerns about the impact of the RO Model. The AAMD was one of over 300 organizations and individuals who submitted comments to CMS.

September 16, 2019: AAMD Letter to CMS

For more information about the RO Model, visit:

CMS website

ASTRO website